XORTX Therapeutics Inc. (TSXV:XRTX)
Canada · Delayed Price · Currency is CAD 0.5700
+0.0800 (16.33%)
At close: Feb 27, 2026
XORTX Therapeutics Market Cap
XORTX Therapeutics has a market cap or net worth of CAD 3.97 million as of March 2, 2026. Its market cap has decreased by -39.95% in one year.
Market Cap
3.97M
Enterprise Value
2.83M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.57
Market Cap Chart
Since January 11, 2018, XORTX Therapeutics's market cap has decreased from 31.46M to 3.97M, a decrease of -87.39%. That is a compound annual growth rate of -22.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 3.97M | -25.97% |
| Dec 30, 2025 | 5.36M | -8.88% |
| Dec 30, 2024 | 5.88M | 1.50% |
| Dec 29, 2023 | 5.80M | -64.03% |
| Dec 30, 2022 | 16.12M | -50.37% |
| Dec 31, 2021 | 32.47M | 175.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 11, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cytophage Technologies | 7.11M |
| BioVaxys Technology | 6.83M |
| PharmaTher Holdings | 6.83M |
| Restart Life Sciences | 5.93M |
| Aptose Biosciences | 5.51M |
| MYND Life Sciences | 5.22M |
| Quest PharmaTech | 5.07M |
| MindBio Therapeutics | 4.60M |